Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...

Once-weekly semaglutide improved glycemia and reduced weight in adults with type 1 diabetes and obesity without increasing hypoglycemia.

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.

“Ozempic teeth is an emerging term that describes a range of dental issues reported by some individuals undergoing treatment with Ozempic (semaglutide), a medication primarily prescribed for ...

Semaglutide is a drug that can be used for weight loss. Oral tablets and injections are both effective ways to take semaglutide.

The new class of weight-loss drugs known as GLP-1s can help reduce a type of heart failure, new research shows, in addition to other heart problems.

A new study shows that semaglutide can improve glucose levels for people with type 1 diabetes who use automated pumps, without increasing hypoglycemia. In this double-blinded randomized trial ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

A growing set of evidence suggests that using semaglutide could lead to decreased substance use, and a large new study shows a promising link between the medications and tobacco use. But experts ...